Last updated: 2026-10-12 20:39:40. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.
West Pharmaceutical Services, Inc. (WST) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NYSE. The stock is currently priced at $367,68, with a market capitalisation of $25,76B and a P/E ratio of 45,60. Over the past 52 weeks, its price has ranged from $223,83 to $386,00. This page covers its latest market performance, valuation, price trends and company information.
$25,76B | |
$366,72 | |
$475,35 | |
$7,68 | |
$366,00 | |
289,89K | |
626,78K | |
45,60 | |
$386,00 | |
$223,83 | |
0,23% | |
-- |
West Pharmaceutical Services, Inc. (WST) is trading at $367,68 in after-hours trading as of 2026-10-12 20:10:00, up 0,46% ($1,68) from the regular-session close of $366,00.
After-hours trading shows how investors are pricing WST after the regular session closes. The current after-hours price is near the regular-session close, indicating positive after-hours sentiment.
Over the past seven days, West Pharmaceutical Services, Inc. (WST) moved from $365,01 to $367,68, representing a gain of 0,73% ($2,67).
The stock traded between $359,49 and $381,16 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.
The average daily volume was 515,43 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 88,7%
WST is currently trading at $367,68, placing it 88,7% of the way from its 52-week low of $223,83 to its 52-week high of $386,00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
West Pharmaceutical Services is based in Pennsylvania and is a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West sells elastomer-based packaging components (including stoppers, seals, and plungers), nonglass containment solutions, and auto-injectors for injectable drugs, which include large-molecule biologics, peptides such as GLP-1 receptor agonists, and small-molecule drugs. The company reports in two segments: proprietary products (about 80% of total revenue) and contract-manufactured products (about 20% of total revenue). It generates approximately 55% of its revenue from international markets and 45% from the United States.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 10800 |
| Exchange | NYSE |
| Company Website |
Eligible investors can buy real shares of West Pharmaceutical Services, Inc. (WST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.